Leiomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
GlobalData estimates that the global leiomyosarcoma therapeutics market was valued at $53.4m in 2011, and is forecast to grow at a high Compound Annual Growth Rate (CAGR) of 9.2% over the next seven years to reach $108.2m by 2019. This fast growth is primarily attributed to the strength of the leiomyosarcoma pipeline, which contains five first-in-class molecules in the late stage of development.
View full press release